Leah Lawrence is a journalist specializing in medical and healthcare topics, with a focus on cancer and dermatology. Her work has been featured in various publications, including Cancer Therapy Advisor, Dermatology Advisor, and Oncology Nurse Advisor. Leah's articles provide valuable insights into the latest research, treatments, and advancements in the field of oncology and dermatology.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Leah's articles predominantly focus on healthcare and pharmaceuticals, specifically cancer research and treatment. Her coverage heavily relies on citing data, indicating a preference for evidence-based information.
To effectively reach Leah, consider providing pitches backed by robust scientific or clinical data related to the topics she covers. Additionally, offering access to experts in the field who can offer insights into recent studies or developments in cancer research and treatment may be beneficial.
Given that Leah has no specified geographic focus, relevant information from any location would likely be of interest as long as it contributes to advancing knowledge within the areas of cancer research and treatment.
This information evolves through artificial intelligence and human feedback. Improve this profile .
TP53 is the most frequently altered gene in human cancers, present in as much as 50% of cases.
Anyone active on social media platforms may have seen posts in recent months urging people to stop wearing sunscreen.
Fewer than three-quarters of adults aged 50 to 75 are up-to-date with recommended colorectal cancer screening, according to recent estimates . Colorectal
By: Leah Lawrence
Olanzapine plus dexamethasone, aprepitant, and palonosetron could be a standard antiemetic therapy option for cancer patients receiving moderately emetogenic chemotherapy, according to researchers.
1.15 (95% CI, 1.02-1.29) for a 1.0 mg/kg dose vs a 0.5 mg/kg dose 1.43 (95% CI, 1.05-1.96) for a 2.0 mg/kg dose vs a 0.5 mg/kg dose
Certain patients diagnosed with chronic lymphocytic leukemia (CLL) will have their disease monitored for changes instead of starting treatment right away.
By: Leah Lawrence
The clinical benefit rate was 40% in patients who received a waiver and 33% in those who did not.
Researchers used artificial intelligence and social media to identify barriers to cancer care for transgender patients. The findings were published in
By: Leah Lawrence
Prostate cancer patients treated with second-generation antiandrogens may have an increased risk of falls, fatigue, and
By: Leah Lawrence
Individuals with a genetic predisposition to celiac disease have an increased risk for nephropathy and chronic glomerulonephritis, as well as a
(833) 317-6278 
